AbbVie Limited - 検索結果

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

viekira pak-rbv

abbvie limited - ombitasvir 12.5mg; paritaprevir 75mg; ritonavir 50mg; dasabuvir sodium monohydrate 270.26mg equivalent to dasabuvir 250 mg; ; ribavirin 400mg; - film coated tablet - active: ombitasvir 12.5mg paritaprevir 75mg ritonavir 50mg excipient: colloidal silicon dioxide copovidone opadry pink 85f140088 propylene glycol monolaurate sodium stearyl fumarate sorbitan laurate tocofersolan active: dasabuvir sodium monohydrate 270.26mg equivalent to dasabuvir 250 mg excipient: colloidal silicon dioxide copovidone croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry beige 85f97497 active: ribavirin 400mg excipient: carnauba wax croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 85f90553 povidone - indicated for the treatment of genotype 1 chronic hepatitis c infection, including patients with compensated cirrhosis, hiv-1 coinfection, and liver transplant recipients. duration of therapy and addition of ribavirin are dependent on patient population.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

viekira pak-rbv

abbvie limited - ombitasvir 12.5mg; paritaprevir 75mg; ritonavir 50mg; dasabuvir sodium monohydrate 270.26mg equivalent to dasabuvir 250 mg; ; ribavirin 600mg; - film coated tablet - active: ombitasvir 12.5mg paritaprevir 75mg ritonavir 50mg excipient: colloidal silicon dioxide copovidone opadry pink 85f140088 propylene glycol monolaurate sodium stearyl fumarate sorbitan laurate tocofersolan active: dasabuvir sodium monohydrate 270.26mg equivalent to dasabuvir 250 mg excipient: colloidal silicon dioxide copovidone croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry beige 85f97497 active: ribavirin 600mg excipient: carnauba wax croscarmellose sodium lactose monohydrate magnesium stearate microcrystalline cellulose opadry blue 85f90623 povidone - indicated for the treatment of genotype 1 chronic hepatitis c infection, including patients with compensated cirrhosis, hiv-1 coinfection, and liver transplant recipients. duration of therapy and addition of ribavirin are dependent on patient population.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

combigan

abbvie limited - brimonidine tartrate 2 mg/ml; ; timolol maleate 6.8 mg/ml equivalent to timolol base 5 mg/ml; - eye drops, solution - 2mg/ml, 5mg/ml - active: brimonidine tartrate 2 mg/ml timolol maleate 6.8 mg/ml equivalent to timolol base 5 mg/ml excipient: benzalkonium chloride dibasic sodium phosphate heptahydrate hydrochloric acid monobasic sodium phosphate monohydrate purified water sodium hydroxide - combigan® eye drops are indicated for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension not adequately responding to monotherapy.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

alphagan

abbvie limited - brimonidine tartrate 2 mg/ml; - eye drops, solution - 0.2 % - active: brimonidine tartrate 2 mg/ml excipient: benzalkonium chloride citric acid monohydrate hydrochloric acid polyvinyl alcohol purified water sodium chloride sodium citrate dihydrate sodium hydroxide - alphagan® eye drops are effective for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.

ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

alphagan p 1.5

abbvie limited - brimonidine tartrate 1.5 mg/ml; - eye drops, solution - 1.5 mg/ml - active: brimonidine tartrate 1.5 mg/ml excipient: boric acid calcium chloride dihydrate carmellose sodium hydrochloric acid magnesium chloride hexahydrate potassium chloride purified water sodium borate pentahydrate sodium chloride sodium chlorite as purite sodium hydroxide - alphagan® p 1.5 eye drops are effective for lowering intraocular pressure in patients with chronic open-angle glaucoma or ocular hypertension.